Hindman Andrew A. Insider Trades

Insider Trading History

Track insider trading activity for Hindman Andrew A.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Theravance Biopharma
Theravance Biopharma TBPH
Director, Svp, CHIEF FINANCIAL OFFICER
Holding Value $7.75M 473,507 shares
Last Trade
Aug 19, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$240k 25,676 shares
$9.34
$16.37
Theravance Biopharma
Theravance Biopharma TBPH
Director, Svp, CHIEF FINANCIAL OFFICER
Holding Value $8.17M 499,183 shares
Last Trade
Jul 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$185k 20,000 shares
$9.24
$16.37
Theravance Biopharma
Theravance Biopharma TBPH
Director, Svp, CHIEF FINANCIAL OFFICER
Holding Value $7.84M 479,183 shares
Last Trade
May 20, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$29.4k 3,365 shares
$8.74
$16.37
Theravance Biopharma
Theravance Biopharma TBPH
Svp, CHIEF FINANCIAL OFFICER
Holding Value $7.88M 481,285 shares
Last Trade
Feb 18, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$250k 25,973 shares
$9.61
$16.37
Theravance Biopharma
Theravance Biopharma TBPH
Svp, Chief Financial Officer
Holding Value $8.3M 507,258 shares
Last Trade
Dec 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.78M 340,000 shares
$8.19
$16.37
Theravance Biopharma
Theravance Biopharma TBPH
Svp, CHIEF FINANCIAL OFFICER
Holding Value $2.74M 167,258 shares
Last Trade
Nov 19, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.3k 1,350 shares
$8.36
$16.37
Theravance Biopharma
Theravance Biopharma TBPH
Svp, Chief Financial Officer
Holding Value $2.74M 167,380 shares
Last Trade
Aug 20, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$245k 17,464 shares
$14.05
$16.37
Theravance Biopharma
Theravance Biopharma TBPH
Svp, Chief Financial Officer
Holding Value $3.03M 184,844 shares
Last Trade
May 20, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$16.8k 942 shares
$17.80
$16.37
Theravance Biopharma
Theravance Biopharma TBPH
Svp, Chief Financial Officer
Holding Value $3.02M 184,704 shares
Last Trade
Feb 20, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$74.9k 3,984 shares
$18.79
$16.37
Theravance Biopharma
Theravance Biopharma TBPH
Svp, Chief Financial Officer
Holding Value $3.09M 188,688 shares
Last Trade
Feb 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.3M 65,000 shares
$20.00
$16.37
Theravance Biopharma
Theravance Biopharma TBPH
Svp, Chief Financial Officer
Holding Value $2.02M 123,135 shares
Last Trade
Aug 20, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$78.8k 4,323 shares
$18.22
$16.37
Theravance Biopharma
Theravance Biopharma TBPH
Svp, Chief Financial Officer
Holding Value $2.09M 127,458 shares
Last Trade
Jul 27, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$416k 20,000 shares
$20.78
$16.37
Theravance Biopharma
Theravance Biopharma TBPH
Svp, Chief Financial Officer
Holding Value $1.74M 106,490 shares
Last Trade
Feb 20, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$183k 7,060 shares
$25.90
$16.37
Theravance Biopharma
Theravance Biopharma TBPH
Svp, Chief Financial Officer
Holding Value $4.26M 260,000 shares
Last Trade
Jul 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.4M 260,000 shares
$16.94
$16.37
Acorda Therapeutics
Acorda Therapeutics ACOR
Chief Business Officer
Holding Value $10.3k 15,639 shares
Last Trade
Mar 08, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.96M 24,120 shares
$81.06
$0.66
Acorda Therapeutics
Acorda Therapeutics ACOR
Chief Business Officer
Holding Value $4.36k 6,594 shares
Last Trade
Feb 21, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$70.4k 877 shares
$80.28
$0.66
Acorda Therapeutics
Acorda Therapeutics ACOR
Chief Business Officer
Holding Value $4.94k 7,471 shares
Last Trade
Dec 22, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$179k 2,300 shares
$77.64
$0.66
Acorda Therapeutics
Acorda Therapeutics ACOR
Chief Business Officer
Holding Value $3.42k 5,171 shares
Last Trade
Dec 03, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$93.9k 753 shares
$124.68
$0.66
Acorda Therapeutics
Acorda Therapeutics ACOR
Chief Business Officer
Holding Value $3.92k 5,924 shares
Last Trade
Nov 05, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$107k 879 shares
$121.68
$0.66
Acorda Therapeutics
Acorda Therapeutics ACOR
Chief Business Officer
Holding Value $4.5k 6,803 shares
Last Trade
Sep 10, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$287k 2,300 shares
$124.80
$0.66

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up